BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Prognosis
44 results:

  • 1. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
    Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
    World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes.
    Alizzi Z; Saravi S; Khalique S; McDonald T; Karteris E; Hall M
    Int J Gynecol Cancer; 2023 Sep; 33(9):1427-1433. PubMed ID: 37541687
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Distinct histological and clinical features associated with pure uterine serous carcinoma: A single institution experience.
    Zhi W; Zhan Y; He C; Jin Y
    Ann Diagn Pathol; 2023 Oct; 66():152173. PubMed ID: 37352704
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A case of ovarian Teratoma with nephroblastoma presenting abdomen metastasis.
    Wu Y; Chu C; Zhang J; Nitish B; Ni J; Xu X
    J Clin Lab Anal; 2022 May; 36(5):e24364. PubMed ID: 35349728
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Wilms' tumor 1 (
    Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
    Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
    Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
    [No Abstract]    [Full Text] [Related]  

  • 7. Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma.
    De Thaye E; Van de Vijver K; Van der Meulen J; Taminau J; Wagemans G; Denys H; Van Dorpe J; Berx G; Ceelen W; Van Bocxlaer J; De Wever O
    Sci Rep; 2020 Apr; 10(1):6688. PubMed ID: 32317693
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A 23-Year-Old Joradanian Woman with a Desmoplastic Small Round Cell Tumor Involving the Ovary.
    Altal OF; Aleshawi AJ; Tashtush NA; Alhowary A
    Am J Case Rep; 2019 Nov; 20():1675-1678. PubMed ID: 31723117
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clonal Evolution of
    Garziera M; Cecchin E; Giorda G; Sorio R; Scalone S; De Mattia E; Roncato R; Gagno S; Poletto E; Romanato L; Ecca F; Canzonieri V; Toffoli G
    Cells; 2019 Oct; 8(10):. PubMed ID: 31581548
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Frequency and Prognostic Significance of the Histologic Type in Early-stage ovarian Carcinoma: A Reclassification Study by the Spanish Group for ovarian cancer Research (GEICO).
    Leskela S; Romero I; Cristobal E; Pérez-Mies B; Rosa-Rosa JM; Gutierrez-Pecharroman A; Santón A; Gonzalez BO; López-Reig R; Hardisson D; Vera-Sempere F; Illueca C; Vieites B; López-Guerrero JA; Palacios J; Poveda A
    Am J Surg Pathol; 2020 Feb; 44(2):149-161. PubMed ID: 31498173
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous ovarian Carcinoma.
    Dieters-Castator DZ; Rambau PF; Kelemen LE; Siegers GM; Lajoie GA; Postovit LM; Köbel M
    Clin Cancer Res; 2019 Jul; 25(14):4309-4319. PubMed ID: 30979743
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological cancers to Induce HLA-A2.1 Restricted CD8
    Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M
    Front Immunol; 2018; 9():2968. PubMed ID: 30631324
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.
    Della Corte L; Giampaolino P; Fabozzi A; Cieri M; Zizolfi B; Morra I; Bifulco G
    Gynecol Endocrinol; 2019 Mar; 35(3):211-213. PubMed ID: 30449229
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunophenotypic profile as a predictor of prognosis in advanced ovarian carcinoma.
    Yokoi A; Matsumoto T; Watanabe G; Tochimoto M; Saegusa M
    Hum Pathol; 2019 Mar; 85():210-220. PubMed ID: 30448218
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ovarian Clear Cell Carcinoma Detected During Long-Term Management of Endometriotic Cysts in Young Patients: Possible Heterogeneity of this Tumor.
    Komiyama S; Nagashima M; Taniguchi T; Yokouchi Y; Kugimiya T
    Gynecol Obstet Invest; 2019; 84(3):305-312. PubMed ID: 30423566
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.
    Wang X; Han L; Zhou L; Wang L; Zhang LM
    Oncol Rep; 2018 Nov; 40(5):2659-2673. PubMed ID: 30226545
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tubo-ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles.
    Magrill J; Karnezis AN; Tessier-Cloutier B; Talhouk A; Kommoss S; Cochrane D; Chow C; Cheng A; Soslow R; Hauptmann S; du Bois A; Pfisterer J; Gilks CB; Huntsman DG; Kommoss F
    Int J Gynecol Pathol; 2019 Nov; 38(6):552-561. PubMed ID: 30059451
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transcription factors wt1 and p53 combined: a prognostic biomarker in ovarian cancer.
    Carter JH; Deddens JA; Mueller G; Lewis TG; Dooley MK; Robillard MC; Frydl M; Duvall L; Pemberton JO; Douglass LE
    Br J Cancer; 2018 Aug; 119(4):462-470. PubMed ID: 30057405
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Pathologic features on gonadal changes of sexual developmental disorders in children].
    Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
    [No Abstract]    [Full Text] [Related]  

  • 20. Wilms' tumor 1 (wt1) as a prognosis factor in gynecological cancers: A meta-analysis.
    Lu J; Gu Y; Li Q; Zhong H; Wang X; Zheng Z; Hu W; Wen L
    Medicine (Baltimore); 2018 Jul; 97(28):e11485. PubMed ID: 29995811
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.